Comparing the Roles of Omalizumab and Ultraviolet Therapy in Treating Severe Pediatric Atopic Dermatitis

JAMA Pediatr. 2021 Feb 1;175(2):205. doi: 10.1001/jamapediatrics.2020.0960.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Allergic Agents* / therapeutic use
  • Child
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Omalizumab / therapeutic use
  • Ultraviolet Therapy*

Substances

  • Anti-Allergic Agents
  • Omalizumab